Todd Boudreau

Today, on May 16th, we recognize Hereditary Angioedema (HAE) Day, a crucial day dedicated to raising awareness about this rare and potentially life-threatening genetic condition. HAE patients often face significant challenges, from severe swelling episodes to the constant uncertainty about when the next attack might occur. At CSL Behring, we are committed to transforming the lives of those affected by HAE. Our cutting-edge treatments and dedication to innovative research have been pivotal in improving the quality of life for patients worldwide. We understand the critical need for effective management and the impact that advanced therapies can have on reducing the burden of this condition. We are proud to be at the forefront of HAE care, providing technologies that not only alleviate symptoms but also empower patients to lead fuller, more active lives. Our mission is to ensure that every patient has access to the best possible care and support. On this Hereditary Angioedema Day, let's stand together in support of the HAE community, acknowledging their strength and resilience. Let’s continue to drive forward with passion and purpose, making a tangible difference in the lives of those who depend on us. #HAEDay #HereditaryAngioedema #CSLBehring #HAEAwareness #PatientCare #InnovativeHealthcare #IWorkforCSL #DrivenbyOurPromise

2

On #MedicalLabWeek Celebrating the committment & tireless work to all of our internal & external lab 🧪 🥼 partners Together we SYNERGIZE efforts towards a COMMON goal improving outcomes for #patients #providers we SERVE 🎯 🧬 🩸 #wintheday Caris Life Sciences 🤝 American Society for Clinical Pathology (ASCP) #pathology #precisionmedicine #ASCPLabWeek24 #results #labweek24

106

2 Comments

We are a week away from the World Orphan Drug Congress (WODC) in Boston. I look forward to seeing several of my current contacts and meeting some new ones. Stop by to see me and the Halloran team to learn about how we support clients developing products for rare and orphan diseases. Set up a meeting with us or visit us at Booth 424 #WODC2024 #regulatory #clinicaldevelopment #quality #compliance #programmanagement

15

Do you feel like you are managing your 340B program all on your own? What if I told you #SUNRx clients enjoy a complete team of #340B experts who work with you to optimize your program to be as compliantly productive as possible? It's true! #SUNRx doesn't just supply you with data, but actually works your program with you. Reach out to me today to learn more!

10

#DYK In some instances, manufacturer assistance programs secure 100% funding to cover the total cost of a drug? That means the member and the plan have a $0 cost share. We take a different and unique approach to Specialty Copay Coupon solutions, compared to our competition. We also offer now offer an integrated MAP/PAP solution, in-house, as well. Message me to find out how MedImpact Healthcare Systems, Inc. can help your organization realize those savings. #wearemedimpact #atruepartner #medication #healthcare

4

1 Comment

The latest U.S. Biotechnology Instruments Market report unveils remarkable growth and new opportunities. Here are 10 essential takeaways for every biotech professional: 1️⃣ Market Growth Projections: The market is set to surge from USD 36.16 billion in 2024 to an impressive USD 49.11 billion by 2033, with a CAGR of 3.46%. 2️⃣ Dominance of Analytical Instruments: Analytical instruments, holding a 65.9% market share in 2023, play a vital role in biotechnological applications, from research to quality control. 3️⃣ Rapid Growth in Cell Culture Instruments: The cell culture instruments segment is poised for the fastest growth through 2033, driven by advancements in biopharmaceuticals, regenerative medicine, and personalized healthcare. 4️⃣ Pharmaceutical & Biotech Companies Lead in End-Use: Dominating the end-use segment with a 40.11% market share in 2023, these companies showcase the industry's dedication to drug discovery and genetic engineering. 5️⃣ Rising Investment in Precision Medicine: With expanding applications, precision medicine presents substantial opportunities, boosting demand for biotechnology instruments crucial for genomic sequencing and biomarker analysis. 6️⃣ Regional Innovation Hubs: California and Massachusetts remain strongholds of biotech innovation, with emerging clusters in Texas and North Carolina contributing significantly to industry growth. 7️⃣ Addressing Regulatory Challenges: Navigating regulatory complexities, especially around gene editing and stem cell research, is crucial for sustaining innovation and market growth. 8️⃣ Global Market Size Estimates: The global biotech instruments market is projected to grow from USD 89.85 billion in 2023 to USD 132.36 billion by 2033, at a CAGR of 3.95%. 9️⃣ Recent Product Innovations: 2024 saw notable advancements, including LICORbio's Odyssey® F biomolecular imaging systems and Waters Corporation’s Alliance iS Bio HPLC System, enhancing productivity and research capabilities. 🔟 Impact of Biopharmaceutical R&D: The expansion of biopharmaceutical R&D, focusing on biologic drugs like monoclonal antibodies and cell therapies, is driving increased demand for sophisticated biotechnology instruments. For those looking to stay ahead, these insights provide a roadmap to understanding market dynamics and seizing growth opportunities. Dive into the full report for an in-depth analysis. Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ https://lnkd.in/dGry4wGJ #Biotech #MarketInsights #Innovation #PrecisionMedicine #Genomics #Biopharmaceuticals #BiotechInvestments #RegulatoryAffairs #BiotechResearch #MarketGrowth Let's continue to elevate the biotech industry together! 🚀

2

Are you following SCA Pharma yet? Give us a follow for important updates, new product launches, trade show information and more. Not a customer yet, now is a perfect time reach out to us to discuss your 503b needs and how SCA can be a valuable partner for your hospital pharmacy. #503b #HospitalPharmacy #Compounding

8

Great to see our ASCO abstract and poster being discussed in the press! 📰 Some of the highlights: 1. Our data shows that most patients with advanced NTRK fusion-positive solid tumors are not getting the right therapy, suggesting that targeted therapy for rarer and/or tissue agnostic alterations may get deprioritized or overlooked 2. Due to the rarity these alterations other personalized medicine drugs, chemotherapy, and immunotherapies may be prioritized- physicians could not be familiar with how to manage those patients with NTRK alterations so they revert to what they know 3. Our poster shows that data-driven digital engagement could help physicians better discern precision treatment opportunities for their patients (DXRX Physician engagement solution) For more details read the article below and get in touch to know more! #precisionmedicine #oncology #biomarkers #ASCO24 #ASCO2024 https://lnkd.in/d-QVfgeJ

16

🚨LAST CHANCE TO REGISTER FOR PRECISION'S UPCOMING EDUCATIONAL WEBINAR!🚨 "What's Up Doc?" Wednesday, June 5, 2024  12:00 pm - 1:00pm CT - 1:00pm - 2:00pm EST UNLIMITED STAFF MAY ATTEND 1.0 CE APPROVED FOR SNF/ALF ADMINISTRATORS & NURSES REGISTER HERE: https://lnkd.in/e6bMVEhR Critical Requirements... MD's & Attending Physicians This program will cover the responsibilities of the Medical Director, as well as the requirements for attending physicians. It is often noted and recent citations show that the Physicians are not documenting in accordance with the total plan of care. We will cover F-Tags involved in MD documentation, as well as an overview of frequently cited deficiencies and compliance tips. WHAT WE WILL COVER ..... Overview and understanding of the Medical Director's role in long term care. An overview and understanding of Physician requirements as noted in the CMS manual (F710-F712.) A review of frequently cited deficiencies and how to prevent them. The Physician's role in quality of care and timely documentation Compliance tips to prevent Physician citations. REGISTER HERE: https://lnkd.in/e6bMVEhR #webinar #healthcare #administrators #nursing #skillednursingfacility #CECredits #FreeCE

1

1 Comment

🚀 ASC BlueButton Project: Leal Health’s Proven Benefits 🚀 The American Cancer Society (ASC) under the BlueButton Project conducted a thorough evaluation to enhance patient enrollment in community settings and streamline oncology clinical trials. Leal Health emerged as the preferred choice after evaluating various direct-to-patient prescreeners. According to the ASC evaluation, Leal Health yielded significant benefits, leading to “a net 91% increase in the number of potential clinical trial matches available within 20 miles of a patient.” This showcases the impactful contributions of Leal Health in advancing patient-centric cancer research and healthcare innovation. For more insights, delve into the complete study here: https://lnkd.in/gAHYbTW4) Feel free to reach out with any inquiries or connect further to explore how Leal Health can cater to your clinical trial requirements. #Oncology #AmericanCancerSociety #ClinicalTrials #PatientEnrollment #HealthcareInnovation #LealHealth #CancerResearch #ASC #PatientCentricity #LealImpact

16

Let ‘s discuss your next theranostic or radiopharm study

5

Check out CTI's Podcast "Moving Medicine Forward," highlighting the work we conduct in Cell and Gene Therapy: 1. Bret Marshall discusses CTI's involvement in Cardiac gene therapy trials, exploring our impact, goals, and industry trends 2. Michael Schmidt and Nicole Sparshott discuss Chain of Custody best practices 3. Joana Lancastre discusses feasibility considerations for Cell and Gene Therapy Trials 4. Jaclyn Guillory shares CTI's experience with enrolling patients to trials with targeted therapies #CTIPodcast #MovingMedicineForward #CRO #ASGCT24 #CellTherapy #GeneTherapy

29

1 Comment

I've learned more in life after a loss than from a win. Here's 8 real-world case studies that reveal the challenges and invaluable lessons learned from drug development programs and clinical trials failing to achieve regulatory approval. https://lnkd.in/e_ahz9tZ #Resilience #GrowthMindset #Leadership #drugdevelopment #drugdiscovery #clinicaltrials #pharmaceutical #biotech #lifesciences

2

Experts at OCT East Coast discuss the integral roles of patients and caregivers throughout a clinical trial’s lifecycle.

1

It’s important to understand the entire patient journey in oncology research. 🔬 My colleague Amy Schroeder and I discuss this topic and other key takeaways from the 2024 NCCN Conference in a new #Avalere video. Listen to the full video here: https://lnkd.in/e7tNs4Hy #oncology #patientjourney #patients #cancercare #NCCN2024

50

#ASCO204 is almost to start. As largest Clinical Oncology meeting it is indeed great opportunity to have productive exchange on clinical trial, program, and portfolio development status in light of incoming updates. #ICON team covering both clinical development strategy as well as operational tactics is at the booth 30119 so stopping by is welcomed. #clinical development #cancer therapy #oncology pipeline #development plan #portfolio optimization #early stage trials #late stage trials #program prioritization

12

3 Comments

Check out Orsini’s latest white paper, exploring the dynamic world of classical hematology. From hemophilia to sickle cell disease, we showcase groundbreaking hematology advancements, uncover trends and hurdles in treatment, and spotlight key payor considerations. Download the white paper now! https://hubs.la/Q02tY91v0 #ClassicalHematology #SpecialtyPharmacy #PatientCare #Hemophilia #SickleCellDisease

2

Sharing this with my network, as I know a few folks are actively looking for their next great adventure in their MSL journey. Please let me know if I can provide an introduction to Leona Blustein, PharmD, MBA

4

To all the moms in #medicalaffairs, this episode’s just for you!

8

1 Comment